Rigel Pharmaceuticals Inc Earnings

The next earnings date for Rigel Pharmaceuticals Inc has not yet been scheduled.

Analyst Estimates of Rigel Pharmaceuticals Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Rigel Pharmaceuticals Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/05/2025Before Market$0.63605.49%
03/04/2025After Market$0.8038.19%
11/07/2024After Market$0.701,066.67%
08/06/2024After Market$-0.0679.31%
05/07/2024After Market$-0.05-66.67%
03/05/2024After Market$0.00114.00%
11/07/2023After Market$-0.0357.14%
08/01/2023After Market$-0.0450.00%
05/02/2023After Market$-0.0820.00%
03/07/2023After Market$0.01109.09%
11/03/2022After Market$-0.1115.38%
08/02/2022After Market$-0.0833.33%
05/03/2022After Market$-0.16-14.29%
03/01/2022After Market$-0.130.00%
11/02/2021After Market$-0.12-20.00%
08/03/2021After Market$-0.0827.27%
05/05/2021After Market$0.222,100.00%
03/02/2021After Market$-0.110.00%
11/05/2020After Market$-0.0833.33%
08/04/2020After Market$-0.1023.08%
05/05/2020After Market$0.130.00%
02/27/2020After Market$-0.10-25.00%
11/05/2019After Market$-0.0736.36%
08/06/2019After Market$-0.1214.29%
05/07/2019After Market$-0.1115.38%
02/28/2019After Market$0.030.00%
11/06/2018After Market$-0.146.67%
08/08/2018After Market$-0.160.00%
05/01/2018After Market$-0.170.00%
03/06/2018After Market$-0.18-38.46%
11/07/2017After Market$-0.146.67%
08/01/2017After Market$-0.16-6.67%
05/02/2017After Market$-0.13-8.33%
03/07/2017After Market$-0.165.88%
11/01/2016After Market$-0.1821.74%
08/02/2016After Market$-0.1525.00%
05/03/2016After Market$-0.190.00%
03/08/2016After Market$-0.14-7.69%
11/03/2015After Market$-0.0852.94%
08/04/2015After Market$-0.1627.27%
05/07/2015After Market$-0.21-16.67%
03/03/2015Before Market$-0.1542.31%
11/04/2014Before Market$-0.2411.11%
08/05/2014---$-0.29-16.00%
05/07/2014---$-0.250.00%
03/04/2014---$-0.1924.00%
11/05/2013---$-0.2513.79%
08/06/2013---$-0.2613.33%
05/07/2013---$-0.293.33%
03/05/2013---$-0.306.25%
11/06/2012---$-0.362.70%
08/07/2012---$-0.350.00%
05/01/2012---$-0.32-3.23%
03/06/2012---$-0.36-28.57%
11/01/2011---$-0.2516.67%
08/02/2011---$-0.372.63%
05/03/2011---$-0.40-11.11%
03/01/2011---$-0.338.33%
11/02/2010---$0.9654.84%
08/03/2010---$0.518.51%
05/04/2010---$-0.43-490.91%
03/02/2010---$-0.48-6.67%
11/03/2009---$-0.70-20.69%
08/04/2009---$-0.810.00%
05/05/2009---$-0.8217.17%
02/24/2009---$-0.916.19%
11/03/2008---$-1.03-18.39%
08/05/2008---$-0.93-34.78%
05/06/2008---$-0.79-27.42%
02/12/2008---$-0.61-41.86%
11/06/2007---$-0.61-7.02%
08/07/2007---$-0.68-7.94%
05/10/2007---$-0.68-1.49%
02/06/2007---$-0.623.13%
11/07/2006---$-0.462.13%
08/02/2006---$-0.0983.93%
05/02/2006---$-0.34-6.25%
02/07/2006---$-0.3616.28%
11/08/2005---$-0.568.20%
08/03/2005---$-0.6212.68%
05/03/2005---$-0.57-18.75%
02/08/2005---$-0.75-8.70%
11/05/2004---$-0.88-23.94%
08/03/2004---$-0.688.11%
05/04/2004---$-0.81-3.85%
02/03/2004---$-0.80-12.68%
11/05/2003---$-7.78---
08/05/2003---$-19.04---
05/06/2003---$-15.33---
02/05/2003---$-1.6225.00%
11/04/2002---$-1.98-10.00%
08/06/2002---$-2.07-53.33%
05/07/2002---$-1.71-11.76%
02/05/2002---$-1.4421.74%
11/07/2001---$-1.530.00%
08/08/2001---$-1.80-81.82%
05/08/2001---$-0.9931.25%
02/07/2001---$-3.24-38.46%

More About Rigel Pharmaceuticals Inc

Website
https://www.rigel.com
Country
USA
Full Time Employees
162

Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer. The company's commercialized products include Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; Rezlidhia, a non-intensive monotherapy to treat adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test; and GAVRETO, a once daily, small molecule, oral, kinase inhibitor for the treatment of adult patients with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC), as well as to treat adult and pediatric patients twelve years of age and older with advanced or metastatic RET fusion-positive thyroid cancer. It also develops R289, an oral interleukin receptor-associated kinases 1 and 4 (IRAK1/4) inhibitor for the treatment of hematology-oncology, autoimmune, and inflammatory diseases, as well as to treat lower-risk myelodysplastic syndrome. In addition, the company has product candidates in clinical development with partners BerGenBio ASA, Eli Lilly and Company, and Daiichi Sankyo. It has strategic development collaboration with The University of Texas MD Anderson Cancer Center for the development of Olutasidenib in AML and other hematologic cancers with IDH1mutations, as well as with collaborative network for neuro-oncology clinical trials to evaluate Olutasidenib in combination with temozolomide in patients with high-grade glioma harboring an IDH1 mutation. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California.

“Rigel Pharmaceuticals Inc Earnings” Can Refer to the Rigel Pharmaceuticals Inc Earnings Date

Some people say “Rigel Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Rigel Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Rigel Pharmaceuticals Inc Stock on the Earnings Date

If you own Rigel Pharmaceuticals Inc stock (RIGL) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Rigel Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Rigel Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Rigel Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Rigel Pharmaceuticals Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.